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Abstract
Introduction Recently, the Breast Cancer Association
Consortium (BCAC) conducted a multi-stage genome-wide
association study and identified 11 single nucleotide
polymorphisms (SNPs) associated with breast cancer risk.
Given the high degree of heritability of mammographic density
and its strong association with breast cancer, it was
hypothesised that breast cancer susceptibility loci may also be
associated with breast density and provide insight into the
biology of breast density and how it influences breast cancer
risk.
Methods We conducted an analysis in the Nurses' Health
Study (n = 1121) to assess the relation between 11 breast
cancer susceptibility loci and mammographic density. At the
time of their mammogram, 217 women were premenopausal
and 904 women were postmenopausal. We used generalised
linear models adjusted for covariates to determine the mean
percentage of breast density according to genotype.

Introduction
Mammographic density is one of the strongest risk factors for
breast cancer. Women with 75% or more breast density are at
a four- to six-fold greater risk of breast cancer than women with
no density [1,2]. The mechanism by which mammographic
density increases breast cancer risk is unclear.
Results from twin studies have estimated that inherited
genetic influences account for 60 to 67% of the variation in
mammographic density [3]. Given its high degree of heritability
[3,4], a number of studies have examined genetic variation and
mammographic density utilising a candidate gene approach

Results Overall, no association between the 11 breast cancer
susceptibility loci and mammographic density was seen. Among
the premenopausal women, three SNPs (rs12443621 [TNRc9/
LOC643714], rs3817198 [lymphocyte-specific protein-1] and
rs4666451) were marginally associated with mammographic
density (p < 0.10). All three of these SNPs showed an
association that was consistent with the direction in which these
alleles influence breast cancer risk. The difference in mean
percentage mammographic density comparing homozygous
wildtypes to homozygous variants ranged from 6.3 to 8.0%.
None of the 11 breast cancer loci were associated with
postmenopausal breast density.

Conclusion Overall, breast cancer susceptibility loci identified
through a genome-wide association study do not appear to be
associated with breast cancer risk.

focusing primarily on polymorphisms in oestrogen synthesis
and metabolising genes with inconclusive results [5-10]. In
addition, polymorphisms in growth factor genes – such as
insulin-like growth factor (IGF)-1 [11], IGF binding protein 3
[12] and pituitary growth hormone [13] – have been reported
to be associated with mammographic density, although these
findings have not yet been examined or replicated in independent studies.
Recently, the Breast Cancer Association Consortium (BCAC)
conducted a multi-stage genome-wide association study of
breast cancer cases and controls and identified 11 single
nucleotide polymorphisms (SNPs) associated with risk [14].

BCAC = Breast Cancer Association Consortium; BMI = Body mass index; CI = Confidence interval; FGFR2 = fibroblast growth factor receptor 2;
LSP1 = lymphocyte-specific protein-1; OR = Odds ratio; SNP = Single nucleotide polymorphism.
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The Nurses' Health Study breast cancer nested case-control
study contributed to the third stage of this genome-wide association study. Given the strong association between mammographic density and breast cancer, breast cancer
susceptibility loci may also be associated with breast density
and provide insight into the biology of breast density and how
it influences breast cancer risk. We conducted a cross-sectional study in the Nurses' Health Study (n = 1121) to assess
the relation between breast cancer susceptibility loci identified
from a multi-stage genome-wide association study and mammographic density.

Materials and methods
The Nurses' Health Study was initiated in 1976, with 121,700
US-registered nurses age 30 to 55 years returning an initial
questionnaire [15]. Information on body mass index (BMI),
reproductive history, age at menopause and postmenopausal
hormone use, as well as diagnosis of cancer and other diseases are updated every two years through questionnaires.
During 1989 and 1990, blood samples were collected from
32,826 women [16]. In general, blood samples were returned
within 26 hours of being drawn and were immediately centrifuged, aliquoted into plasma, red blood cells and buffy coat
fractions, and stored in liquid nitrogen freezers. The follow-up
rate among women who provided blood samples was 99%
through 1998.
We conducted a cross-sectional analysis among controls from
a breast cancer case-control study nested within the Nurses'
Health Study cohort. This nested case-control study included
breast cancer cases diagnosed after blood collection but
before 1 June 1998 and matched controls [17]. The collection
of film mammograms was targeted to breast cancer cases and
matched controls through the 1998 follow-up cycle. We collected mammograms taken as close as possible to the date of
blood collection (1989 to 1990). This collection has been
described in detail in a previous publication [11].
This study was approved by the Committee on the Use of
Human Subjects in Research at Brigham and Women's Hospital.
To assess mammographic density, the craniocaudal views of
both breasts were digitised at 261 microns/pixel with a Lumysis 85 laser film scanner, which covers a range of 0 to 4.0 optical density. The software for computer-assisted thresholding
was developed at the University of Toronto [18] and this measure of mammographic breast density was highly reproducible
within this study [19]. We used the average percentage density of both breasts for this analysis. We also evaluated the
association of these SNPs with the absolute area of mammographic density, but because results were similar and percentage breast density has been a stronger predictor of breast
cancer risk than area of dense tissue in many [1,20-23] but not
all [24] studies, we present the results for percentage mam-
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mographic density as our primary analyses and include the
association with dense and non-dense area in supplementary
tables.
As part of the third stage of the BCAC multi-stage genomewide association study, 30 SNPs were genotyped in the
Nurses' Health Study breast cancer nested case-control samples. Although genotype data are available for all 30 SNPs, we
present results for the 11 SNPs reported to be associated
with breast cancer after all three stages as our primary results.
Analyses examining the association between the other 19
SNPs and breast density were considered secondary (see
supplementary table 1 in additional data file 1).
Genotyping was conducted using a fluorescent 5' endonuclease assay and the ABI-PRISM 7900 (Taqman) for sequence
detection. For quality control, about 10% of samples were
Table 1
Descriptive characteristics of study population (n = 1121) at the
time of mammography, Nurses' Health Study (1989–1998)
Characteristic
Mean values
Age, y
Body mass index,

kg/m2

Mean

SD

58.4

7.3

25.6

4.6

27.1

20.6

N

%

Premenopausal

217

19.4

Postmenopausal/never user

371

33.1

Postmenopausal/past user

317

28.3

Postmenopausal/current user

216

19.3

None

327

31.8

<5 g/day

346

33.6

5 to 14.9 g/day

221

21.5

15+ g/day

135

13.1

Nulliparous

83

7.5

Parous/<25 years

549

49.6

Parous/25 to 29 years

382

34.5

Parous/>30

93

8.4

Prior benign breast disease

465

41.5

Family history of breast cancer

135

12.0

Percentage mammographic density, %

Frequenciesa
Menopausal/hormone status

Alcohol consumption

Parity/age at first birth

a Numbers

may not be added to total due to missing data.
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included as blinded duplicates in the genotyping runs. The
concordance for replicate samples was more than 99%.

time of their mammograms. European ancestry was selfreported by 98.8% of the women in the study.

We used generalised linear models adjusted for covariates to
determine the mean percentage breast density according to
genotype. To determine if there was a linear trend with increasing variant alleles, we calculated p values from Wald statistics
including an ordinal variable for genotype regressed on square
root transformed percentage mammographic density. Covariate information at the time of the mammogram was assessed
using data from biennial questionnaires completed before the
date of the mammogram. Although it is unlikely that these factors are confounders of the genotype and mammographic
density relationship, these variables do explain the substantial
variation in the outcome. In addition, genetic variants may be
associated with mammographic density through its association with other covariates, such as BMI. Because our goal was
to determine if breast cancer susceptibility loci are associated
with mammographic density independent of factors know to
influence breast density, we included known predictors of
mammographic density in multivariate models.

Overall, there was no significant association between the 11
breast cancer susceptibility loci and mammographic density
(Table 2). Of the 11 breast cancer susceptibility loci, three
were associated with premenopausal mammographic density
at p < 0.10 (Table 3). The variant allele of rs12443621
(TNRc9/LOC643714) was positively associated with mammographic density; the mean percentage mammographic density among homozygous variants (42.5%) was 6.3%
percentage points greater than those homozygous for the
wildtype allele (36.2%). This association was primarily due to
the association with dense area (p = 0.04; see supplementary
Table 2 in additional file 2), rather than non-dense area (p =
0.30; see supplementary Table 3 in additional file 3). The variant allele of rs3817198 (lymphocyte-specific protein-1
[LSP1]) was positively associated with mammographic density; the mean percentage mammographic density among
homozygous variants (41.0%) was 7.5% percentage points
greater than those homozygous for the wildtype allele
(33.5%). This association also appears to be due to the association with dense area (p = 0.04; see supplementary Table 2
in additional file 2), rather than with non-dense area (p = 0.15;
see supplementary Table 3 in additional file 3). The variant
allele of rs4666451 was inversely associated with mammographic density; the mean percentage mammographic density
among homozygous variants (33.6%) was 8.0% percentage
points lower than those homozygous for the wildtype allele
(41.6%). In contrast, this association was primarily due to the
association with non-dense area (p-trend = 0.02; see supplementary Table 3 in additional file 3), rather than with dense
area (p-trend = 0.22; see supplementary Table 2 in additional
file 2). None of the 11 breast cancer loci were associated with
postmenopausal breast density (Table 3). We also conducted
secondary analyses among postmenopausal women
restricted to women who were not taking postmenopausal
hormones at the time of mammography (n = 688). In general,
these results were consistent with results among all postmenopausal women (data not shown).

Percentage mammographic density is considerably lower in
postmenopausal women than in premenopausal women. It has
been suggested that premenopausal breast density may be
more highly heritable than postmenopausal density [25], and
that different genes may be associated with premenopausal
density rather than with postmenopausal density [26]. We
therefore a priori considered that genes may differentially be
associated with premenopausal and postmenopausal mammographic density. Because there was evidence that the
association between some of the breast cancer susceptibility
loci and breast density varied according to menopausal status
at mammogram we included results stratified by menopausal
status. Data analysis was conducted using SAS statistical
software version 9.1. All p values presented are two-sided
tests of statistical significance.

Results
This study examined the association between 11 breast cancer susceptibility loci and mammographic density in 1121
women in the Nurses' Health Study. The mean age of participants at the time of mammography was 58.4 years (Table 1).
At the time of their mammogram, 217 women were premenopausal, with a mean (SD) age at mammography of 49.1 (3.3)
years. Among premenopausal women, the mean percentage
mammographic density was 39.7 (22.2)% (range 0.6 to
90.3%). At the time of their mammogram, 904 women were
postmenopausal with a mean age at mammography of 60.6
(6.2) years. Among postmenopausal women, the mean percentage mammographic density was 24.1 (19.0)% (range 0.0
to 86.5%). Of the postmenopausal women, 41% had never
used postmenopausal hormones, 24% were currently using
postmenopausal hormones and 35% were former users at the

In a secondary analysis, we examined the 19 additional SNPs
that were genotyped in this study population as part of stage
3 of the genome-wide association study (see supplementary
Table 1 in additional file 1) but were reported to not be significantly associated with breast cancer after the final stage. Two
of these SNPs (rs6843340 and rs2298075) were associated
with mammographic density in the population overall.
rs6843340 was associated with both premenopausal and
postmenopausal density, while rs2298075 was associated
with only postmenopausal density (see supplementary Table 4
in additional file 4). In addition, rs10508468 was associated
with premenopausal breast density and rs6469633 was associated with postmenopausal breast density only (see supplementary Table 4 in additional file 4).
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Table 2
Mean percentage of mammographic density (MD) according to breast cancer susceptibility loci, Nurses' Health Study controls (1989
to 1998)

rs2981582

p value

N

Mean %MDa

Mean %MDb

G/G

421

26.9

26.7

G/A

539

26.9

26.6

A/A

160

26.8

28.0

0.56

0.98

d

rs12443621

A/A

298

25.0

25.7

A/G

561

27.3

26.9

G/G

267

27.4

27.1

0.12

0.25

p value d
rs13281615

p value

A/A

377

27.6

27.2

A/G

553

25.9

26.3

G/G

198

28.1

27.5

0.90

0.91

d

rs3817198

A/A

489

26.0

25.9

A/G

491

27.8

27.8

G/G

119

25.9

26.1

0.95

0.79

p value d
rs889312

p value

T/T

622

28.3

28.2

T/G

428

24.7

25.1

G/G

76

28.6

27.3

0.12

0.06

d

rs4666451

G/G

405

26.9

27.4

A/G

531

27.2

26.7

A/A

184

25.7

25.8

0.43

0.13

p value d
rs2107425

p value

G/G

572

27.5

27.5

G/A

440

25.8

25.8

A/A

108

26.7

26.3

0.39

0.24

d

rs981782

A/A

336

27.9

27.0

A/C

544

26.5

26.9

C/C

231

26.7

26.8

0.15

0.40

p value d
rs8051542

p value

G/G

307

26.8

26.8

G/A

383

25.7

25.6

A/A

173

29.3

29.2

0.67

0.64

d

rs30099
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C/C

929

26.9

27.0

C/T

193

26.0

25.5
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Table 2 (Continued)
Mean percentage of mammographic density (MD) according to breast cancer susceptibility loci, Nurses' Health Study controls (1989
to 1998)
T/T
p value

8

d

rs3803662

28.0

24.0

0.81

0.28

26.2

26.4

G/G

590

G/A

434

27.5

26.9

A/A

90

27.1

28.6

0.53

0.37

p value d
aAge adjusted.
bMultivariate adjusted

for the following: age (continuous), body mass index (BMI) (continuous), alcohol consumption (none, <5 g/day, 5 to 14.9 g/
day, 15+ g/day), age at first birth/parity (nulliparous, age at first birth <25, age at first birth 25 to 29, age at first birth >30), history of benign breast
disease (yes/no), family history of breast cancer (yes/no).
cMultivariate adjusted for the following: age, BMI, alcohol consumption, age at first birth/parity, history of benign breast disease, family history of
breast cancer, postmenopausal status/hormone use (premenopausal, never user, current user, past user).
dp value based on genotype coded as ordinal variable regressed on square root transformed MD.

Discussion
In this study, we found that overall none of the breast cancer
susceptibility loci were associated with mammographic density. However, some breast cancer susceptibility loci were
associated with premenopausal breast density. We did not
observe an association between any of these loci and postmenopausal breast density. These loci were originally identified from a three-stage genome-wide association study. The
first stage of the genome-wide association study was among
390 breast cancer patients selected with a strong family history of breast cancer of at least two affected first-degree family
relatives and 364 controls [14]. Women with a family history
are more likely to develop breast cancer at an early age. It is
known that some breast cancer risk factors are differentially
associated with premenopausal and postmenopausal breast
cancer [27], hence it may be the case that the specific gene
contribution to density may also vary by menopausal status.
However, multiple lines of evidence suggest that the determinants of breast density may differ at different ages [26,28,29].
Thus, it is possible that different sets of genetic variants may
be highly associated with premenopausal and postmenopausal breast density. If this is the case it may explain why these
SNPs were associated with premenopausal breast density
only and not postmenopausal breast density.
A limitation of the current study is the relatively small number
of premenopausal women with density measurements (n =
217). Given the number of tests conducted, it is possible that
these findings are the result of chance. However, the direction
and strength of the association observed between the three
polymorphisms and premenopausal mammographic density
suggest that these genes may play an important role in determining premenopausal breast density. All three associated
SNPs are consistent with the direction in which these alleles
influence breast cancer risk [14]. The variant alleles of both
rs12443621 and rs3817198 were associated with increasing
breast density in this study and with increasing breast cancer

risk in the BCAC (Odds ratio [OR] for rs12443621
homozygous variant vs homozygous wildtype = 1.23, 95%
confidence interval [CI] 1.17 to 1.30 [14]; OR for rs3817198
homozygous variant vs homozygous wildtype = 1.17, 95%CI
1.08 to 1.25 [14]). The variant allele of rs4666451 was
inversely associated with breast density and with a reduced
risk of breast cancer in the genome-wide association study
(OR homozygous variant vs homozygous wildtype = 0.93,
95%CI 0.87 to 0.99) [14]. In addition, the difference in mean
percentage mammographic density comparing homozygous
wildtypes to homozygous variants ranged from 6.3 to 8.0 percentage points. These differences in mammographic density
are in the same range that has been associated previously with
changes in mammographic density observed with exposure to
postmenopausal hormones[30,31] and tamoxifen [32]. It is
estimated that a 5% higher mammographic density is associated with a 7% increase in breast cancer risk [1]; thus, the
estimated risk of breast cancer associated with these three
SNPs, and attributable to their influence on mammographic
density, would therefore range from 1.09 to 1.12.
Two of the three SNPs associated with premenopausal breast
density are in known genes: TNRc9/LOC643714
(rs12443621) and LSP1. It is unclear what the function of the
TNRc9 (also known as TOX3) gene is; however, it contains a
putative high mobility group box motif which suggests that it
may act as a transcription factor and this gene has been implicated in breast cancer metastasis to the bone [33]. Another
variant in the TNRc9 gene (rs3803662) also emerged from an
independent genome-wide association study of oestrogenreceptor positive breast cancer in an Icelandic population
[34]. rs3817198 in the LSP1 gene (also known as WP43) is
a cytoskeletal protein expressed in haematopoietic and
endothelial cells. rs4666451 is located on 2p with no known
gene function, although the region did appear in genome-wide
linkage analyses of familial breast cancer [35]. It remains to be
seen whether these SNPs exhibit their influence on breast
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Table 3
Mean percentage mammographic density (MD) according to breast cancer susceptibility loci, Nurses' Health Study controls
(1989–1998)
Premenopausal (n = 217)

rs2981582

N

Mean %MDa

Mean %MDb

N

Mean %MDa

Mean %MDc

G/G

73

37.4

37.9

332

24.4

24.2

G/A

112

40.5

40.7

407

23.9

23.6

A/A

28

41.7

38.4

131

23.7

25.3

0.27

0.62

0.34

0.82

p value d
rs12443621

p value

A/A

51

36.0

36.2

236

22.9

23.4

A/G

104

38.9

39.1

442

24.5

24.2

G/G

54

43.7

42.5

202

23.5

23.8

0.05

0.06

0.70

0.72

d

rs13281615

A/A

70

39.7

38.2

290

25.2

25.0

A/G

94

36.0

38.2

445

23.7

23.9

G/G

47

144

p value d
rs3817198

p value

p value

p value

396

24.2

24.0

A/G

106

42.6

42.3

368

24.4

24.6

G/G

20

39.5

41.0

93

22.7

22.8

0.04

0.01

0.39

0.56

41.1

41.3

499

25.6

25.4

T/T

107

T/G

89

38.5

38.2

321

21.5

22.1

G/G

14

38.8

37.2

58

26.8

25.3

0.40

0.21

0.17

0.14

G/G

74

40.7

41.6

314

24.0

24.5

A/G

96

40.6

39.5

418

24.2

23.8

A/A

36

33.0

33.6

144

24.3

24.3

0.13

0.06

0.90

0.40

G/G

105

41.7

40.7

449

24.3

24.6

G/A

87

36.8

37.2

337

23.4

23.3

A/A

18

85

39.6
0.29

24.6

23.6

0.79

0.37

64

37.7

37.5

258

25.5

24.6

A/C

100

39.4

39.2

429

23.7

24.1

C/C

47

42.3

42.5

175

23.2

23.4

0.39

0.27

0.08

0.22

G/G

63

41.0

40.5

234

23.2

23.4

G/A

73

40.0

40.1

296

22.3

22.3

A/A

32

137

p value d
rs30099

37.5
0.11

A/A

d

rs8051542

22.8
0.32

33.5

p value d
rs981782

22.9
0.36

33.9

d

rs2107425

43.1
0.52

80

p value d
rs4666451

45.8
0.45

A/A

d

rs889312

Postmenopausal (n = 904)

C/C
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175

37.9

37.8

0.58

0.65

38.8

38.8

723

27.6

27.3

0.36

0.43

24.4

24.5
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Table 3 (Continued)
Mean percentage mammographic density (MD) according to breast cancer susceptibility loci, Nurses' Health Study controls
(1989–1998)

p value

C/T

34

T/T

0

d

rs3803662

p value d

40.5

39.9

0.45

0.51

151

22.6

22.4

8

26.0

21.8

0.49

0.16

G/G

107

37.0

36.9

458

23.9

24.1

G/A

77

43.9

42.7

344

24.0

23.4

A/A

20

32.7

36.1

69

26.5

28.0

0.55

0.34

0.64

0.50

aAge adjusted.
bMultivariate adjusted

for the following: age (continuous), body mass index (BMI) (continuous), alcohol consumption (none, <5 g/day, 5 to 14.9 g/
day, 15+ g/day), age at first birth/parity (nulliparous, age at first birth <25, age at first birth 25 to 29, age at first birth >30), history of benign
breast disease (yes/no), family history of breast cancer (yes/no).
cMultivariate adjusted for the following: age, BMI, alcohol consumption, age at first birth/parity, history of benign breast disease, family history of
breast cancer, postmenopausal hormone use (never user, current user, past user).
dp value based on genotype coded as ordinal variable regressed on square root transformed MD.

cancer risk through mammographic density. Because these
SNPs are associated with modest associations in breast cancer risk, larger studies with premenopausal density measurements on breast cancer cases and controls will be necessary
to address this question.
SNPs in intron 2 of fibroblast growth factor receptor 2
(FGFR2) have emerged as top hits from multiple genome-wide
association studies of breast cancer [14,36]. We did not
detect an association between an FGFR2 (rs2981582) SNP
and breast density in the current study. Homozygous variants
of rs2981582 or other SNPs in high linkage disequilibrium are
estimated to confer about a 60% increase in breast cancer
risk relative to homozygous wildtypes [14,36]. Assuming the
association between FGFR2 variants and breast cancer is
mediated through breast density, one would expect to see a
33% difference in mammographic density comparing
homozygous variants with homozygous wildtypes. The current
study consisted of sufficiently high numbers of both premenopausal and postmenopausal women to detect such a difference. The lack of association of the SNP in FGFR2 and other
breast cancer loci with breast density in this study suggests
that some genes influence breast cancer risk independent of
breast density.
Our primary analyses focused on the 11 SNPs identified after
a multi-stage genome-wide association study with p ≤ 0.001
in the combined analysis. We also examined 20 additional
SNPs that were either no longer significant at this cutoff or not
consistent with the direction originally observed. There is suggestive evidence that three of these SNPs (rs2298075,
rs684340 and rs6469633) are associated with breast density
in a direction consistent with the observed association with
breast cancer risk. The p value in the combined BCAC study
for these three SNPs ranged from 0.002 to 0.13. Thus
although they were not considered significantly associated

with breast cancer at the defined cutoff, their borderline significance with breast cancer risk and consistent association with
breast density warrant further investigation of these SNPs in
relation to breast density and breast cancer risk.
To our knowledge, this is the first study to examine the association between these replicated breast cancer susceptibility
loci and mammographic density in a cancer-free population.
Lee and colleagues [37] genotyped six breast cancer susceptibility loci identified from genome-wide association studies
among 516 young (<50 years of age) breast cancer patients.
Five of these six SNPs were included in the present study.
Overall, they observed no association between the SNPs and
mammographic density. However, among women with oestrogen-receptor positive breast cancer rs3817198 was associated with mammographic density (p = 0.02). The direction of
the association observed was consistent with our findings
among premenopausal women.
The majority of the current study population was postmenopausal at the time of mammography and we were limited by
the number of premenopausal women with breast density
measurements. Given that the first stage of the genome-wide
association study was among women with a strong family history, these SNPs may be more likely to be associated with premenopausal density. It remains to be seen whether other
breast cancer susceptibility loci from other study designs are
associated with postmenopausal breast density.

Conclusion
Overall, breast cancer susceptibility loci identified through a
genome-wide association study do not appear to be associated with breast cancer risk.
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